Genopathy
Gene-Disorder Association · Article
Gene
NTRK3
Neurotrophic Receptor Tyrosine Kinase 3
Disorder
Melanoma
First reported 2003
Supporting publications 1
Key publication · gene–disorder Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas.Oncology · 2003
Key publication · disorder The properties and surgical problems of malignant melanoma.Annals of the Royal College of Surgeons of England · 1950
Manually curated
Association Review

In brief

The association between NTRK3 (Neurotrophic Receptor Tyrosine Kinase 3) and Melanoma is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 2
Compounds 0
Trials 0
Publications 1
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
NTRK3

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Melanoma

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
06
Provenance

References & sources

4 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access